Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Analog 23 is a promising compound for prostate cancer treatment.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

The hydrogel effectively treats dental implant issues by killing bacteria, reducing inflammation, and improving implant success.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Using existing drugs for new treatments is cost-effective and safer.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A new mutation in the HJV gene was found in a young woman with juvenile hemochromatosis, causing unusual symptoms like secondary hypothyroidism.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

A new, quick method detects minoxidil using silver nanoparticles.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.